Covaxin: Delhi proposes, Bharat Biotech disposes, says Dy CM Sisodia

The Delhi government cries foul over Bharat Biotech turning down its request for Covaxin supply; Centre's directive to company behind the denial, says Delhi Deputy CM Manish Sisodia

What India needs for its people and economy: COVID vaccines, in quick time

As the COVID caselood spikes and the economy takes a battering, only a well thought out and implemented vaccination strategy can mitigate the situation; India needs its vaccines quickly, in huge numbers, without policy flipflops

Number of new COVID cases peaks, but big variations among states, UTs

India reported a record 414,188 new cases on May 7 – about 32 per cent higher than the world’s previous peak reported by the US last year, but with just a fraction of the testing and vast undercounting

Indian regulators authorise Covaxin trials in children aged 2 to 18

The aim of the trials will be to evaluate the vaccine’s safety, reactogenicity and immunogenicity in children. All these parameters are necessary for granting approval for mass use

Priyanka takes Centre to task for failing to secure COVID vaccines

Senior Congress leader Priyanka Gandhi Vadra on Wednesday (May 12) taunted the NDA government for celebrating ‘Tika Utsa...

India records highest COVID deaths of 4,204 in 24-hrs; 3.48L new infections

India’s COVID fatality toll touched a deadly high of 4,205 in the last 24 hours, taking the total death toll to 2,54,197...

COVID mutant fear grips India but TN sends fewer genome survey samples

Tamil Nadu is among the few states which have not sent enough samples for genome survey. As per the data released by INS...

WHO has not labelled B.1.617 as ‘Indian variant’, asserts Centre

The Centre on Wednesday (May 12) has clarified that the World Health Organisation (WHO) has not classified the B.1.617 coronavirus variant as 'Indian' as widely reported and stressed that the word 'Indian' has not been used in its report. 

Why Indian variant of COVID-19 is now a threat to global health

A variant can be labelled as “of concern” if it has been shown to be more contagious, more deadly or more resistant to current vaccines and treatments